Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
841 to 860 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| R01CA181429 | Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma | 1 | 2018 |
| R01CA182746 | GENOMIC HARBINGERS OF BRAIN METASTASIS IN NON SMALL CELL LUNG CANCER | 1 | 2018 |
| R01CA186568 | Spatially-resolved proteomic mapping of living cells | 1 | 2018 |
| R01CA194094 | Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML | 1 | 2018 |
| R01ES002710 | Hydrolytic enzymes in the metabolism of toxins | 1 | 2018 |
| R01ES012974 | Epigenetic Transgenerational Endocrine Disruptor Actions | 1 | 2018 |
| R01GM108904 | Fitness and Modularity of Stochastic Variation in Protein Expression Levels | 1 | 2018 |
| R01HL075360 | Systems Biology of Macrophage Polarizaiton Following Myocardial Infarction | 1 | 2018 |
| R01HL121019 | Mechanisms of intermittent parathyroid hormone effects on calcific aortic disease | 1 | 2018 |
| R01HL122887 | Integrative Omics as a Discovery Tool for Pulmonary Hypertension | 1 | 2018 |
| R01HL124187 | Therapeutic Mechanisms of Human CD34 Exosomes | 1 | 2018 |
| R01HL125583 | INTEGRATIVE GENOMICS OF CLINICAL SUBTYPES IN COPDGENE | 1 | 2018 |
| R01HL125735 | Splenic Marginal Zone Macrophages in Chronic Ischemic Heart Failure | 1 | 2018 |
| R01HL125821 | Signaling pathways in lung stem cell differentiation | 1 | 2018 |
| R01HL128170 | A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling | 1 | 2018 |
| R01HL129178 | Role of mesenchymal-endothelial-transition in cardiac hypertrophy | 1 | 2018 |
| R01NS091307 | Statistical Methods for Clinical Trials with Multivariate Longitudinal Outcomes | 1 | 2018 |
| R15NS104857 | MECHANISMS AND MODULATORS OF RESILIENCE TO DOPAMINERGIC NEURODEGENERATION | 1 | 2018 |
| R15NS108815 | Nanodiamond based anti-HIV drug delivery targeted towards the brain | 1 | 2018 |
| R21AA025841 | Alcohol enhances colon cancer liver metastasis via cancer-associated fibroblasts | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=43